$11.47
6.50%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US15687V1098
Symbol
CERT

Certara Stock price

$11.47
+0.85 8.00% 1M
-1.08 8.61% 6M
+0.82 7.70% YTD
-1.53 11.77% 1Y
-4.45 27.95% 3Y
-26.61 69.88% 5Y
-26.61 69.88% 10Y
-26.61 69.88% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.70 6.50%

Key metrics

Basic
Market capitalization
$1.8b
Enterprise Value
$2.0b
Net debt
$131.9m
Cash
$162.3m
Shares outstanding
160.6m
Valuation (TTM | estimate)
P/E
229.4 | 24.2
P/S
4.5 | 4.3
EV/Sales
4.9 | 4.6
EV/FCF
25.5
P/B
1.7
Financial Health
Equity Ratio
67.2%
Return on Equity
-1.1%
ROCE
1.8%
ROIC
1.4%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$405.8m | $429.5m
EBITDA
$81.3m | $136.4m
EBIT
$25.8m | $122.4m
Net Income
$8.0m | $76.1m
Free Cash Flow
$77.5m
Growth (TTM | estimate)
Revenue
11.6% | 11.5%
EBITDA
474.2% | 162.9%
EBIT
136.0% | 7,174.6%
Net Income
110.1% | 731.5%
Free Cash Flow
52.7%
Margin (TTM | estimate)
Gross
61.1%
EBITDA
20.0% | 31.7%
EBIT
6.4%
Net
2.0% | 17.7%
Free Cash Flow
19.1%
More
EPS
$0.1
FCF per Share
$0.5
Short interest
9.3%
Employees
2k
Rev per Employee
$250.0k
Show more

Is Certara a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Certara Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Certara forecast:

10x Buy
59%
7x Hold
41%

Analyst Opinions

17 Analysts have issued a Certara forecast:

Buy
59%
Hold
41%

Financial data from Certara

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
406 406
12% 12%
100%
- Direct Costs 158 158
6% 6%
39%
248 248
16% 16%
61%
- Selling and Administrative Expenses 131 131
13% 13%
32%
- Research and Development Expense 36 36
7% 7%
9%
81 81
474% 474%
20%
- Depreciation and Amortization 56 56
11% 11%
14%
EBIT (Operating Income) EBIT 26 26
136% 136%
6%
Net Profit 7.98 7.98
110% 110%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Certara directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Certara Stock News

Neutral
Seeking Alpha
18 days ago
Certara, Inc. (NASDAQ:CERT ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants John E. Gallagher - SVP, Principal Accounting Officer & Chief Financial Officer William F.
Positive
The Motley Fool
18 days ago
Certara (CERT -3.35%), a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue beat, with reported GAAP revenue of $104.6 million, exceeding analyst expectations, but non-GAAP earnings per share (EPS) missed consensus by $0.03.
Neutral
GlobeNewsWire
18 days ago
RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025.
More Certara News

Company Profile

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.

Head office United States
CEO William Feehery
Employees 1,517
Founded 2008
Website www.certara.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today